Jim Frates

Jim Frates

Director of Finance/CFO presso AMYLYX PHARMACEUTICALS, INC.

Patrimonio netto: 770 401 $ in data 31/03/2024

56 anni
Consumer Services
Commercial Services
Health Technology

Profilo

James M.
Frates
is currently the Director at St. Francis House, Independent Director at SAGE Therapeutics, Inc., and Chief Financial Officer at Amylyx Pharmaceuticals, Inc. He previously worked as the Director at GPC Biotech AG and National Director at The Association of Bioscience Financial Officers.
He was also the Vice President-Investment Banking at Robertson Stephens & Co. and the Chief Financial Officer & Senior Vice President at Alkermes Plc.
Frates has served as Treasurer & Trustee at St. Paul's School and Roxbury Latin School.
Frates holds an MBA degree from Harvard Business School and an undergraduate degree from Harvard College.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
16/04/2024 252 495 ( 0.37% ) 717 086 $ 31/03/2024
03/01/2024 2 845 ( 0.00% ) 53 315 $ 31/03/2024

Posizioni attive di Jim Frates

SocietàPosizioneInizio
SAGE THERAPEUTICS, INC. Director/Board Member 10/06/2014
AMYLYX PHARMACEUTICALS, INC. Director of Finance/CFO 01/01/2021
Director/Board Member -
Tutte le posizioni attive di Jim Frates

Precedenti posizioni note di Jim Frates

SocietàPosizioneFine
ALKERMES PLC Director of Finance/CFO 11/01/2021
Director/Board Member 01/06/2009
Director/Board Member 01/01/2009
Robertson Stephens & Co. Corporate Officer/Principal 01/06/1998
Roxbury Latin School Director/Board Member -
Vedi nel dettaglio l'esperienza di Jim Frates

Formazione di Jim Frates

Harvard Business School Masters Business Admin
Harvard College Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jim Frates

Relazioni

98

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
SAGE THERAPEUTICS, INC.

Health Technology

ALKERMES PLC

Health Technology

Aziende private5

Commercial Services

Robertson Stephens & Co.

Finance

Commercial Services

Commercial Services

Amylyx Pharmaceuticals, Inc.

Vedi le connessioni aziendali